| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044845609 |
| P356 | DOI | 10.1038/SJ.ONC.1210461 |
| P698 | PubMed publication ID | 17452981 |
| P5875 | ResearchGate publication ID | 6376037 |
| P2093 | author name string | F Sato | |
| T Ito | |||
| E Montgomery | |||
| J Yang | |||
| Y Cheng | |||
| Y Mori | |||
| Z Jin | |||
| J M Abraham | |||
| S J Meltzer | |||
| J P Hamilton | |||
| R Agarwal | |||
| S David | |||
| T Kan | |||
| D Beer | |||
| A Olaru | |||
| B Paun | |||
| P2860 | cites work | Two genetic hits (more or less) to cancer | Q22251289 |
| Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats | Q24309127 | ||
| Craniosynostosis in transgenic mice overexpressing Nell-1 | Q24553230 | ||
| Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk | Q28244692 | ||
| Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development | Q28569383 | ||
| Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C | Q28581222 | ||
| The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data | Q31919142 | ||
| Roles of cell division and gene transcription in the methylation of CpG islands. | Q33959680 | ||
| Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation | Q35030679 | ||
| Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites | Q36115450 | ||
| Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine). | Q36279309 | ||
| Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents | Q36345472 | ||
| New gene, nel, encoding a Mr 93 K protein with EGF‐like repeats is strongly expressed in neural tissues of early stage chick embryos | Q36692178 | ||
| Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia. | Q40458280 | ||
| Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence | Q42671396 | ||
| Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years | Q44291344 | ||
| Nell-1 induces acrania-like cranioskeletal deformities during mouse embryonic development. | Q45962386 | ||
| Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma | Q46062133 | ||
| Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects | Q46282179 | ||
| A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. | Q53342370 | ||
| Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. | Q53411176 | ||
| Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma | Q82967811 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| hypermethylation | Q106875739 | ||
| P304 | page(s) | 6332-6340 | |
| P577 | publication date | 2007-04-23 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma | |
| P478 | volume | 26 |
| Q41897097 | A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus |
| Q85637871 | Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma |
| Q92539287 | Age dependent effects of NELL-1 isoforms on bone marrow stromal cells |
| Q38213141 | Biomarkers for dysplastic Barrett's: ready for prime time? |
| Q91289594 | Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway |
| Q44067402 | Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma |
| Q45017704 | DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma |
| Q89896747 | Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients |
| Q26825349 | Early events during neoplastic progression in Barrett's esophagus |
| Q37228130 | Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer |
| Q37992481 | Epigenetic biomarkers in esophageal cancer |
| Q49663292 | Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives |
| Q35674241 | Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma. |
| Q35666522 | Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q37037246 | Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers |
| Q39993768 | Genome-wide profiling of DNA methylation in human cancer cells |
| Q55024946 | Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis. |
| Q36725997 | Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma |
| Q29617664 | Landscape of somatic retrotransposition in human cancers |
| Q35668216 | MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric Cancer |
| Q36336519 | Matching cancer genomes to established cell lines for personalized oncology |
| Q33840504 | Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma |
| Q24309477 | NELL-1 binds to APR3 affecting human osteoblast proliferation and differentiation |
| Q36699479 | NELL-1 expression in tumors of cartilage |
| Q36018565 | NELL-1 in the treatment of osteoporotic bone loss. |
| Q33798085 | NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair. |
| Q39314285 | NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation |
| Q33779367 | NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma |
| Q90698512 | Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond |
| Q38149245 | Novel diagnostic and prognostic biomarkers in esophageal cancer |
| Q37354050 | Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma |
| Q30857110 | Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. |
| Q24632246 | Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma |
| Q26750641 | The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma |
| Q39380189 | The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread |
| Q37812294 | The value of epigenetic markers in esophageal cancer |
| Q50176590 | Whole genome DNA methylation profiling of oral cancer in ethnic population of Meghalaya, North East India reveals novel genes |
| Q33869648 | Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis |
Search more.